Tovetumab

DB12609InvestigationalProtein Based Therapies

Tovetumab has been used in trials studying the treatment of Cancer, Glioblastoma Multiforme, and Advanced Solid Malignancies.

Mechanism: Pharmacologically active on Platelet-derived growth factor receptor alpha
Curator reviewed
Code names: MEDI-575

Resolves to

Compound

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

382Drug interactionsStructured to mechanism, not free text

4Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Tovetumab, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.